About this trial
IMMO-LDRT02 is a prospective, placebo-controlled, double-blind, randomized trial to investigate the clinical efficacy of low dose radiation therapy (LDRT) in the treatment of arthrosis. Newly diagnosed or already existing arthroses of the fingers, wrists, shoulders, knees, ankles and feet will be enclosed. Finally, the evidence of clinical benefit from LDRT (6 x 0.5 Gy) will be compared to the placebo group (6 x 0 Gy), by determination via a visual analog scale and identification of immunological changes.
Eligibility criteria
Qualifiers
Finger and wrist osteoarthritis
Elbow arthrosis
Shoulder arthrosis
Knee arthrosis
Disqualifiers
Patients with tumor diseases
People capable of childbearing or procreation who do not take consistent contraceptive measures during therapy
Persistent drug, medication or alcohol abuse
Patients for whom, in the physician's judgment, participation is not justifiable with regard to their well-being due to temporary withdrawal of standard medication.
Trial design
Treatments tested in this trial
- low dose radiotherapy (0.5 Gy)
- mock radiation treatment
- low dose radiotherapy (1.0 Gy)
Treatment groups
Sponsors and collaborators
University of Erlangen-Nürnberg Medical School
Lead sponsor
Johann Wolfgang Goethe University Hospital
Collaborator